Table 5. Multivariable predictors of coronary plaque progression.

Variable	Univariable Analysis			Multivariable Analysis
	OR	95%CI	p value	OR	95%CI	p value
Low cholesterol at baseline*	4.068	1.798–9.205	0.001	3.689	1.502–9.059	0.004
Age	1.064	1.022–1.108	0.002	1.048	1.003–1.095	0.036
Men	0.707	0.270–1.853	0.48
Body mass index (kg/mm2)	0.956	0.853–1.072	0.45
Diabetes Mellitus	1.907	0.909–3.999	0.088	1.973	0.851–4.574	0.11
Hypertension	2.889	1.294–6.451	0.010	2.369	0.940–5.971	0.067
Allocated Pitavastatin	0.674	0.325–1.400	0.29
Unstable angina pectoris	0.791	0.356–1.757	0.57
Left anterior descending	1.105	0.532–2.296	0.79
Left circumflex	1.131	0.182–7.029	0.90
Right	0.884	0.421–1.857	0.75
Drug-eluting stent use	0.707	0.270–1.853	0.48
ACE-I or ARB	2.265	1.077–4.765	0.031	1.248	0.516–3.017	0.62
β-blocker	1.162	0.366–3.693	0.80
Calcium channel blocker	1.810	0.868–3.773	0.11
Glucose (mg/dl) at baseline	1.003	0.992–1.015	0.55
hs-CRP (µg/ml) at baseline	1.003	9.90–1.016	0.62
Baseline plaque volume (mm3)	0.999	0.997–1.002	0.646

^*non-high-density lipoprotein cholesterol ≦ 140mg/dl; ACE-I indicates, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; hs-CRP, high-sensitivity C-reactive protein